Results 1 to 10 of about 67,047,750 (228)
Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides [PDF]
Frontiers in Cardiovascular Medicine, 2021 This review summarizes current knowledge regarding clinical epidemiology, pathophysiology, and prognosis for patients with HFmrEF in comparison to HFrEF and HFpEF. Although recommended treatments currently focus on aggressive management of comorbidities,
Kaiyuan Zhu +8 more
doaj +2 more sources
Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines [PDF]
ESC Heart Failure, 2020 Currently, the assessment of left ventricular ejection fraction (LVEF) is the cornerstone of the classification of patients with heart failure (HF). The mid‐range LVEF (HFmrEF) category was identified in an attempt to uncover specific characteristics of ...
Luca Branca +3 more
doaj +2 more sources
Heart failure with mid-range ejection fraction. Where are we today? [PDF]
Българска кардиология, 2021 Bulgarian Society of Cardiology adhere to the European Guidelines on Heart Failure (HF). The fi nalized studies and many debates and analyses after 2016 are prerequisite to creation of a new guideline for diagnosis and management on these patients.
Tzvetana Katova
doaj +4 more sources
Тhe uncharted middle ground – when the patient asks, but the guideliness don’t answer [PDF]
Българска кардиология, 2021 Heart failure takes up an increasing portion of everyday cardiology practice. The accumulation of knowledge about the range of phenotypes and the therapeutic responses across the spectrum of heart failure leads to dynamic reconsideration of the best ...
Iskra Bayraktarova, Tzvetana Katova
doaj +3 more sources
Heart failure with mildly reduced ejection fraction: emerging frontiers in clinical characteristics, prognosis, and treatment [PDF]
Reviews in Cardiovascular Medicine, 2022 Heart failure (HF) is a complex clinical syndrome resulting from the impairment of ventricular filling or ejection of blood or both, leading to considerable morbidity and mortality. Based on left ventricular ejection fraction (LVEF), the 2016 European
Zhi Shang, Xinyu Wang, Wei Gao
doaj +1 more source
Similarities and Differences Between HFmrEF and HFpEF
Frontiers in Cardiovascular Medicine, 2021 The new guidelines classify heart failure (HF) into three subgroups based on the ejection fraction (EF): HF with reduced EF (HFrEF), HF with mid-range EF (HFmrEF), and HF with preserved EF (HFpEF).
Peixin Li +15 more
doaj +1 more source
Heart Failure with Mid-range Ejection Fraction——a Comprehension of the Disease [PDF]
Zhongguo quanke yixue, 2022 Heart failure is the final main battlefield of various cardiovascular diseases with huge harm, which can cause all kinds of arrhythmias and even sudden cardiac death. The 2016 ESC guidelines formally define heart failure with mid-range ejection fraction (
RUAN Zheng, HUANG Jianyu, JIANG Wencai, CHEN Meixiang, QIN Changyu, XU Lin
doaj +1 more source
Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
Biomolecules, 2020 Heart Failure (HF) is a syndrome, which implies the existence of different phenotypes. The new categorization includes patients with preserved ejection fraction (HFpEF), mid-range EF (HFmrEF), and reduced EF (HFrEF) but the molecular mechanisms involved ...
Valeria Conti +14 more
doaj +1 more source
ESC Heart Failure, 2022 Aims In the heart failure (HF) with preserved ejection fraction (HFpEF) PARAGON‐HF trial, sacubitril/valsartan vs. valsartan improved mortality/morbidity in patients with left ventricular ejection fraction (LVEF) below median (57%).
Lars H. Lund +9 more
doaj +1 more source
ESC Heart Failure, 2021 Aims The role of diastolic dysfunction (DD) in prognostic evaluation in heart failure (HF) patients with impaired systolic function remains unclear.
Dan Liu +9 more
doaj +1 more source